The DOI matches its Crossref record; 70 of the 70 references it cites were found in a registry or an index.
PTEN hamartoma tumor syndromes
Open accessAbstract
The PTEN hamartoma tumor syndromes (PHTS) are a collection of rare clinical syndromes characterized by germline mutations of the tumor suppressor PTEN. These syndromes are driven by cellular overgrowth, leading to benign hamartomas in virtually any organ. Cowden syndrome (CS), the prototypic PHTS syndrome, is associated with increased susceptibility to breast, thyroid, and endometrial cancer. PTEN is located on chromosome 10q22–23 and negatively regulates the prosurvival PI3K/Akt/mTOR pathway through its lipid phosphatase activity. Loss of PTEN activates this pathway and leads to increased cellular growth, migration, proliferation, and survival. Clinical management of patients with PHTS, particularly those with CS, should include early and frequent screening, surveillance, and preventive care for associated malignancies. Concomitant with improved understanding of the biology of PTEN and the PI3K/Akt/mTOR pathway, inhibitors of this pathway are being developed as anticancer agents. These medications could have applications for patients with PHTS, for whom no medical options currently exist.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
mTOR Inhibition Induces Upstream Receptor Tyrosine Kinase Signaling and Activates Akt
O'Reilly, K. E., Rojo, F., She, Q.-B., Solit, D., Mills, G. B., Smith, D., Lane, H., Hofmann, F., Hicklin, D. J., Ludwig, D. L., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2925 · Cited by 2,561
Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN
Stambolic, V., Suzuki, A., de la Pompa, J. L., Brothers, G. M., Mirtsos, C., Sasaki, T., Ruland, J., Penninger, J. M., Siderovski, D. P., & Mak, T. W. (1998) · Cell · doi:10.1016/s0092-8674(00)81780-8 · Cited by 2,551
Liaw, D., Marsh, D. J., Li, J., Dahia, P. L. M., Wang, S. I., Zheng, Z., Bose, S., Call, K. M., Tsou, H. C., Peacoke, M., et al. (1997) · Nature Genetics · doi:10.1038/ng0597-64 · Cited by 2,091
Pten is essential for embryonic development and tumour suppression
Cristofano, A. D., Pesce, B., Cordon-Cardo, C., & Pandolfi, P. P. (1998) · Nature Genetics · doi:10.1038/1235 · Cited by 1,516
Fisher, B., Costantino, J. P., Wickerham, D. L., Cecchini, R. S., Cronin, W. M., Robidoux, A., Bevers, T. B., Kavanah, M. T., Atkins, J. N., Margolese, R. G., et al. (2005) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dji372 · Cited by 1,339
Sirolimus for Angiomyolipoma in Tuberous Sclerosis Complex or Lymphangioleiomyomatosis
Bissler, J. J., McCormack, F. X., Young, L. R., Elwing, J. M., Chuck, G., Leonard, J. M., Schmithorst, V. J., Laor, T., Brody, A. S., Bean, J., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa063564 · Cited by 1,253
Inhibition of cell migration, spreading, and focal adhesions by tumor suppressor PTEN
Tamura, M., Gu, J., Matsumoto, K., Aota, S.-I., Parsons, R., & Yamada, K. M. (1998) · Science · doi:10.1126/science.280.5369.1614 · Cited by 1,215
Yang, H., Kong, W., He, L., Zhao, J.-J., O'Donnell, J. D., Wang, J., Wenham, R. M., Coppola, D., Kruk, P. A., Nicosia, S. V., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-2488 · Cited by 1,051
Essential role for nuclear PTEN in maintaining chromosomal integrity
Shen, W. H., Balajee, A. S., Wang, J., Wu, H., Eng, C., Pandolfi, P. P., & Yin, Y. (2007) · Cell · doi:10.1016/j.cell.2006.11.042 · Cited by 979
Breast Cancer after Prophylactic Bilateral Mastectomy in Women with a BRCA1 or BRCA2 Mutation
Meijers-Heijboer, H., van Geel, B., van Putten, W. L. J., Henzen-Logmans, S. C., Seynaeve, C., Menke-Pluymers, M. B. E., Bartels, C. C. M., Verhoog, L. C., van den Ouweland, A. M. W., Niermeijer, M. F., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200107193450301 · Cited by 973
Enhanced sensitivity of PTEN-deficient tumors to inhibition of FRAP/mTOR
Neshat, M. S., Mellinghoff, I. K., Tran, C., Stiles, B., Thomas, G., Petersen, R., Frost, P., Gibbons, J. J., Wu, H., & Sawyers, C. L. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.171076798 · Cited by 969
Mutation of Pten/Mmac1 in mice causes neoplasia in multiple organ systems
Podsypanina, K., Ellenson, L. H., Nemes, A., Gu, J., Tamura, M., Yamada, K. M., Cordon-Cardo, C., Catoretti, G., Fisher, P. E., & Parsons, R. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.4.1563 · Cited by 946
Fujio, Y., Nguyen, T., Wencker, D., Kitsis, R. N., & Walsh, K. (2000) · Circulation · doi:10.1161/01.cir.101.6.660 · Cited by 847
Suzuki, A., de la Pompa, J. L., Stambolic, V., Elia, A. J., Sasaki, T., Barrantes, I. D. B., Ho, A., Wakeham, A., ltie, A., Khoo, W., et al. (1998) · Current Biology · doi:10.1016/s0960-9822(07)00488-5 · Cited by 818
Sun, S.-Y., Rosenberg, L. M., Wang, X., Zhou, Z., Yue, P., Fu, H., & Khuri, F. R. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0917 · Cited by 802
PTEN: One Gene, Many Syndromes
Eng, C. (2003) · Human Mutation · doi:10.1002/humu.10257 · Cited by 787
Rapamycin induces feedback activation of Akt signaling through an IGF-1R-dependent mechanism
Wan, X., Harkavy, B., Shen, N., Grohar, P., & Helman, L. J. (2007) · Oncogene · doi:10.1038/sj.onc.1209990 · Cited by 755
Ubiquitination regulates PTEN nuclear import and tumor suppression
Trotman, L. C., Wang, X., Alimonti, A., Chen, Z., Teruya-Feldstein, J., Yang, H., Pavletich, N. P., Carver, B. S., Cordon-Cardo, C., Erdjument-Bromage, H., et al. (2007) · Cell · doi:10.1016/j.cell.2006.11.040 · Cited by 748 · cited 1×
“29 overexpression of the NEDD4 E3-ubiquitin protein that leads to degradation of PTEN in the proteasome”
BackgroundEfficacy of Bilateral Prophylactic Mastectomy in BRCA1 and BRCA2 Gene Mutation Carriers
Hartmann, L. C., Sellers, T. A., Schaid, D. J., Frank, T. S., Soderberg, C. L., Sitta, D. L., Frost, M. H., Grant, C. S., Donohue, J. H., Woods, J. E., et al. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.21.1633 · Cited by 743
NEDD4-1 Is a Proto-Oncogenic Ubiquitin Ligase for PTEN
Wang, X., Trotman, L. C., Koppie, T., Alimonti, A., Chen, Z., Gao, Z., Wang, J., Erdjument-Bromage, H., Tempst, P., Cordon-Cardo, C., et al. (2007) · Cell · doi:10.1016/j.cell.2006.11.039 · Cited by 720
PTEN: Life as a Tumor Suppressor
Simpson, L., & Parsons, R. (2001) · Experimental Cell Research · doi:10.1006/excr.2000.5130 · Cited by 679
Marsh, D. (1998) · Human Molecular Genetics · doi:10.1093/hmg/7.3.507 · Cited by 653
Marsh, D. J., Kum, J. B., Lunetta, K. L., Bennett, M. J., Gorlin, R. J., Ahmed, S. F., Bodurtha, J., Crowe, C., Curtis, M. A., Dasouki, M., et al. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.8.1461 · Cited by 612
Cloughesy, T. F., Yoshimoto, K., Nghiemphu, P., Brown, K., Dang, J., Zhu, S., Hsueh, T., Chen, Y., Wang, W., Youngkin, D., et al. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050008 · Cited by 593
Cowden's Disease: A Possible New Symptom Complex with Multiple System Involvement
LLOYD, K. M., & DENNIS, M. (1963) · Annals of Internal Medicine · doi:10.7326/0003-4819-58-1-136 · Cited by 580
An inhibitor of mTOR reduces neoplasia and normalizes p70/S6 kinase activity in Pten+/−mice
Podsypanina, K., Lee, R. T., Politis, C., Hennessy, I., Crane, A., Puc, J., Neshat, M., Wang, H., Yang, L., Gibbons, J., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.171060098 · Cited by 569
Will the real Cowden syndrome please stand up: revised diagnostic criteria
Eng, C. (2000) · Journal of Medical Genetics · doi:10.1136/jmg.37.11.828 · Cited by 566
The Cowden syndrome: a clinical and genetic study in 21 patients
Starink, T. M., Veen, J. P. W. V. D., Arwert, F., Waal, L. P. D., Lange, G. G. D., Gille, J. J. P., & Eriksson, A. W. (1986) · Clinical Genetics · doi:10.1111/j.1399-0004.1986.tb00816.x · Cited by 550
Growth suppression of glioma cells by PTEN requires a functional phosphatase catalytic domain
Furnari, F. B., Lin, H., Huang, H.-J. S., & Cavenee, W. K. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.23.12479 · Cited by 434
Wiedemann, H. R., Burgio, G. R., Aldenhoff, P., Kunze, J., Kaufmann, H. J., & Schirg, E. (1983) · European Journal of Pediatrics · doi:10.1007/bf00661895 · Cited by 421
Yu, K., Toral-Barza, L., Discafani, C., Zhang, W. G., Skotnicki, J., Frost, P., & Gibbons, J. J. (2001) · Endocrine-related cancer · doi:10.1677/erc.0.0080249 · Cited by 420
Growth-suppressive effects of BPOZ and EGR2, two genes involved in the PTEN signaling pathway
Unoki, M., & Nakamura, Y. (2001) · Oncogene · doi:10.1038/sj.onc.1204608 · Cited by 381
Beilina, A., Van Der Brug, M., Ahmad, R., Kesavapany, S., Miller, D. W., Petsko, G. A., & Cookson, M. R. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0500617102 · Cited by 381
Pilarski, R., & Eng, C. (2004) · Journal of Medical Genetics · doi:10.1136/jmg.2004.018036 · Cited by 329
Vogel, V. G., Costantino, J. P., Wickerham, D. L., Cronin, W. M., Cecchini, R. S., Atkins, J. N., Bevers, T. B., Fehrenbacher, L., Pajon, E. R., Wade, J. L., et al. (2006) · Obstetrical & Gynecological Survey · doi:10.1097/01.ogx.0000238648.23538.42 · Cited by 329
Tan, W.-H., Baris, H. N., Burrows, P. E., Robson, C. D., Alomari, A. I., Mulliken, J. B., Fishman, S. J., & Irons, M. B. (2007) · Journal of Medical Genetics · doi:10.1136/jmg.2007.048934 · Cited by 304
Zhou, X.-P., Waite, K. A., Pilarski, R., Hampel, H., Fernandez, M. J., Bos, C., Dasouki, M., Feldman, G. L., Greenberg, L. A., Ivanovich, J., et al. (2003) · The American Journal of Human Genetics · doi:10.1086/377109 · Cited by 285
Epigenetic Silencing of the PTEN Gene in Melanoma
Mirmohammadsadegh, A., Marini, A., Nambiar, S., Hassan, M., Tannapfel, A., Ruzicka, T., & Hengge, U. R. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0384 · Cited by 279
Mutation screening of the PTEN gene in patients with autism spectrum disorders and macrocephaly
Buxbaum, J. D., Cai, G., Chaste, P., Nygren, G., Goldsmith, J., Reichert, J., Anckarsäter, H., Rastam, M., Smith, C. J., Silverman, J. M., et al. (2007) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30493 · Cited by 269
Cancer phenomics: RET and PTEN as illustrative models
Zbuk, K. M., & Eng, C. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2037 · Cited by 239
Molecular Classification of Patients With Unexplained Hamartomatous and Hyperplastic Polyposis
Sweet, K. (2005) · JAMA · doi:10.1001/jama.294.19.2465 · Cited by 234
Enhanced sensitivity of multiple myeloma cells containing PTEN mutations to CCI-779.
Shi, Y., Gera, J., Hu, L., Hsu, J.-H., Bookstein, R., Li, W., & Lichtenstein, A. K. (2002) · PubMed · Cited by 231
Zhou, X.-P., Marsh, D. J., Morrison, C. D., Chaudhury, A. R., Maxwell, M., Reifenberger, G., & Eng, C. (2003) · The American Journal of Human Genetics · doi:10.1086/379382 · Cited by 229
Zhou, X.-P., Hampel, H., Thiele, H., Gorlin, R. J., Hennekam, R. C., Parisi, M., Winter, R. M., & Eng, C. (2001) · The Lancet · doi:10.1016/s0140-6736(01)05412-5 · Cited by 225
Weng, L.-P. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.6.605 · Cited by 199
Lachlan, K. L., Lucassen, A. M., Bunyan, D., & Temple, I. K. (2007) · Journal of Medical Genetics · doi:10.1136/jmg.2007.049981 · Cited by 198
Schrager, C. A., Schneider, D., Gruener, A. C., Tsou, H. C., & Peacocke, M. (1998) · Human Pathology · doi:10.1016/s0046-8177(98)90389-6 · Cited by 193
Fan, Q.-W., Cheng, C. K., Nicolaides, T. P., Hackett, C. S., Knight, Z. A., Shokat, K. M., & Weiss, W. A. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-2154 · Cited by 192
Male breast cancer in Cowden syndrome patients with germline PTEN mutations
Fackenthal, J. D., Marsh, D. J., Richardson, A.-L., Cummings, S. A., Eng, C., Robinson, B. G., & Olopade, O. I. (2001) · Journal of Medical Genetics · doi:10.1136/jmg.38.3.159 · Cited by 190
Ždychová, J., & Komers, R. (2005) · Physiological Research · doi:10.33549/physiolres.930582 · Cited by 184
Incidence of Metachronous Testicular Cancer in Patients With Extragonadal Germ Cell Tumors
Hartmann, J. T., Fossa, S. D., Nichols, C. R., Droz, J.-P., Horwich, A., Gerl, A., Beyer, J., Pont, J., Fizazi, K., Hecker, H., et al. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.22.1733 · Cited by 162
Large genomic deletions of SMAD4, BMPR1A and PTEN in juvenile polyposis
van Hattem, W. A., Brosens, L. A. A., de Leng, W. W. J., Morsink, F. H. M., Lens, S. I., Carvalho, R., Giardiello, F. M., & Offerhaus, G. J. A. (2008) · Gut · doi:10.1136/gut.2007.142927 · Cited by 155
Caux, F. A., Plauchu, H., Chibon, F., Faivre, L. O., Fain, O., Vabres, P., Bonnet, F., Selma, Z. B., Laroche, L., Gérard, M., et al. (2007) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5201823 · Cited by 149
Gustafson, S. L., Zbuk, K. M., Scacheri, C., & Eng, C. (2007) · Seminars in Oncology · doi:10.1053/j.seminoncol.2007.07.009 · Cited by 148
Rapamycin treatment for a child with germline PTEN mutation
Marsh, D. J., Trahair, T. N., Martin, J. L., Chee, W. Y., Walker, J. L., Kirk, E. P., Baxter, R. C., & Marshall, G. M. (2008) · Nature Clinical Practice Oncology · doi:10.1038/ncponc1112 · Cited by 143
Thyroid pathologic findings in patients with Cowden disease
Harach, H. R., Soubeyran, I., Brown, A., Bonneau, D., & Longy, M. (1999) · Annals of Diagnostic Pathology · doi:10.1016/s1092-9134(99)80011-2 · Cited by 140
Abel, T. W., Baker, S. J., Fraser, M. M., Tihan, T., Nelson, J. S., Yachnis, A. T., Bouffard, J., Mena, H., Burger, P. C., & Eberhart, C. G. (2005) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/64.4.341 · Cited by 132
Germline mutation of the tumour suppressor PTEN in Proteus syndrome
Smith, J. M., Kirk, E. P. E., Theodosopoulos, G., Marshall, G. M., Walker, J., Rogers, M., Field, M., Brereton, J. J., & Marsh, D. J. (2002) · Journal of Medical Genetics · doi:10.1136/jmg.39.12.937 · Cited by 124
Davies, M. A., Kim, S. J., Parikh, N. U., Dong, Z., Bucana, C. D., & Gallick, G. E. (2002) · PubMed · Cited by 110
Reardon, W., Zhou, X.-P., & Eng, C. (2001) · Journal of Medical Genetics · doi:10.1136/jmg.38.12.820 · Cited by 109
Cowden disease. Report of a family and review.
Longy, M., & Lacombe, D. (1996) · PubMed · Cited by 109
Lipomatosis, angiomatosis, and macrencephalia. A previously undescribed congenital syndrome.
Ga, B. (1971) · PubMed · Cited by 104
Parisi, M. A., Dinulos, M. B., Leppig, K. A., Sybert, V. P., Eng, C., & Hudgins, L. (2001) · Journal of Medical Genetics · doi:10.1136/jmg.38.1.52 · Cited by 92
McGarrity, T. J., Baker, M. J., Ruggiero, F. M., Thiboutot, D. M., Hampel, H., Zhou, X.-P., & Eng, C. (2003) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2003.07496.x · Cited by 85
Agrawal, S., & Eng, C. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddi492 · Cited by 76
Proteus syndrome: Misdiagnosis with PTEN mutations
M. Michael Cohen, Turner, J. T., & Biesecker, L. G. (2003) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.20474 · Cited by 60
Sarquis, M., Agrawal, S., Shen, L., Pilarski, R., Zhou, X.-P., & Eng, C. (2006) · The American Journal of Human Genetics · doi:10.1086/504392 · Cited by 50
Susceptibility to Breast Cancer: Hereditary Syndromes and Low Penetrance Genes
Nusbaum, R., Vogel, K. J., & Ready, K. (2007) · Breast Disease · doi:10.3233/bd-2007-27103 · Cited by 38
Papadopoulos, K. P., Markman, B., Tabernero, J. M., Patnaik, A., Heath, E. I., DeCillis, A. P., Laird, D., Aggarwal, S. K., Nguyen, L., & LoRusso, P. M. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.26.15_suppl.3510 · Cited by 26
Cited by
American Cancer Society Guidelines for Breast Screening with MRI as an Adjunct to Mammography
Saslow, D., Boetes, C., Burke, W., Harms, S., Leach, M. O., Lehman, C. D., Morris, E., Pisano, E., Schnall, M., Sener, S., et al. (2007) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.57.2.75 · Cited by 2,637
PTEN loss in the continuum of common cancers, rare syndromes and mouse models
Hollander, M. C., Blumenthal, G. M., & Dennis, P. A. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3037 · Cited by 794
Self-citationPilarski, R., Burt, R., Kohlman, W., Pho, L., Shannon, K. M., & Swisher, E. (2013) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djt277 · Cited by 654
Genetic/Familial High-Risk Assessment: Breast and Ovarian
Daly, M. B., Axilbund, J. E., Buys, S., Crawford, B., Farrell, C. D., Friedman, S., Garber, J. E., Goorha, S., Gruber, S. B., Hampel, H., et al. (2010) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2010.0043 · Cited by 646
Thioredoxin and Thioredoxin Target Proteins: From Molecular Mechanisms to Functional Significance
Lee, S., Kim, S. M., & Lee, R. T. (2013) · Antioxidants & Redox Signaling · doi:10.1089/ars.2011.4322 · Cited by 433
Metadata
- Authors
- Blumenthal, G. M., & Dennis, P. A.
- Venue
- European Journal of Human Genetics
- Published
- 2008-09-10
- Volume
- 16
- Issue
- 11
- Pages
- 1289-1300
- ISSN
- 1018-4813 (ISSN-L)
- 1476-5438
- OpenAlex
- W2010288342
- Cited by
- 327
- References
- 70
- FWCI
- 6.45
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.